Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Immunology and Cell Biology
|
August 1, 1993
Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis
B R Yacyshyn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
New biotechnological therapies for Crohn's disease: where are we now?
B R Yacyshyn
Diseases of the Colon and Rectum
|
October 5, 2001
The concept and application of antisense oligonucleotides
B R Yacyshyn, S T Crooke
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
January 14, 2000
Making sense of antisense
B R Yacyshyn, W R Shanahan
Gastroenterology
|
January 1, 1995
CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
B R Yacyshyn, J B Meddings
Digestive Diseases (Basel, Switzerland)
|
March 30, 2001
Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding
B R Yacyshyn, A B Thomson
Gut
|
December 1, 1993
Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease
B R Yacyshyn, L M Pilarski
Digestion
|
November 13, 2002
The clinical importance of proton pump inhibitor pharmacokinetics
B R Yacyshyn, A B R Thomson
Transplantation
|
January 1, 1994
Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero
L M Pilarski, B R Yacyshyn, A I Lazarovits
Gastroenterology
|
November 1, 1994
Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns
B R Yacyshyn, A Lazarovits, V Tsai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Immunology and Cell Biology
|
August 1, 1993
Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis
B R Yacyshyn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
New biotechnological therapies for Crohn's disease: where are we now?
B R Yacyshyn
Diseases of the Colon and Rectum
|
October 5, 2001
The concept and application of antisense oligonucleotides
B R Yacyshyn, S T Crooke
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
January 14, 2000
Making sense of antisense
B R Yacyshyn, W R Shanahan
Gastroenterology
|
January 1, 1995
CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
B R Yacyshyn, J B Meddings
Digestive Diseases (Basel, Switzerland)
|
March 30, 2001
Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding
B R Yacyshyn, A B Thomson
Gut
|
December 1, 1993
Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease
B R Yacyshyn, L M Pilarski
Digestion
|
November 13, 2002
The clinical importance of proton pump inhibitor pharmacokinetics
B R Yacyshyn, A B R Thomson
Transplantation
|
January 1, 1994
Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero
L M Pilarski, B R Yacyshyn, A I Lazarovits
Gastroenterology
|
November 1, 1994
Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns
B R Yacyshyn, A Lazarovits, V Tsai, et al.
Page
of 3